GTBP
Price
$2.99
Change
-$0.00 (-0.00%)
Updated
Nov 6 closing price
VKTX
Price
$65.87
Change
-$0.00 (-0.00%)
Updated
Nov 6 closing price
90 days until earnings call
Ad is loading...

GTBP vs VKTX

Header iconGTBP vs VKTX Comparison
Open Charts GTBP vs VKTXBanner chart's image
GT Biopharma
Price$2.99
Change-$0.00 (-0.00%)
Volume$9.33K
CapitalizationN/A
Viking Therapeutics
Price$65.87
Change-$0.00 (-0.00%)
Volume$5.94M
CapitalizationN/A
View a ticker or compare two or three
GTBP vs VKTX Comparison Chart
Loading...
GTBP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
GTBP vs. VKTX commentary
Nov 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GTBP is a Buy and VKTX is a Buy.

COMPARISON
Comparison
Nov 08, 2024
Stock price -- (GTBP: $2.99 vs. VKTX: $65.88)
Brand notoriety: GTBP and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GTBP: 52% vs. VKTX: 133%
Market capitalization -- GTBP: $6.68M vs. VKTX: $7.34B
GTBP [@Biotechnology] is valued at $6.68M. VKTX’s [@Biotechnology] market capitalization is $7.34B. The market cap for tickers in the [@Biotechnology] industry ranges from $486.24B to $0. The average market capitalization across the [@Biotechnology] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GTBP’s FA Score shows that 1 FA rating(s) are green whileVKTX’s FA Score has 1 green FA rating(s).

  • GTBP’s FA Score: 1 green, 4 red.
  • VKTX’s FA Score: 1 green, 4 red.
According to our system of comparison, VKTX is a better buy in the long-term than GTBP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GTBP’s TA Score shows that 6 TA indicator(s) are bullish while VKTX’s TA Score has 4 bullish TA indicator(s).

  • GTBP’s TA Score: 6 bullish, 4 bearish.
  • VKTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, GTBP is a better buy in the short-term than VKTX.

Price Growth

GTBP (@Biotechnology) experienced а -0.66% price change this week, while VKTX (@Biotechnology) price change was -8.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.10%. For the same industry, the average monthly price growth was +12.99%, and the average quarterly price growth was +10.90%.

Reported Earning Dates

GTBP is expected to report earnings on May 13, 2024.

VKTX is expected to report earnings on Feb 05, 2025.

Industries' Descriptions

@Biotechnology (+3.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VKTX($7.34B) has a higher market cap than GTBP($6.68M). VKTX YTD gains are higher at: 254.003 vs. GTBP (-60.915). GTBP has higher annual earnings (EBITDA): -11.35M vs. VKTX (-133.66M). VKTX has more cash in the bank: 930M vs. GTBP (9.25M). GTBP has less debt than VKTX: GTBP (0) vs VKTX (1.24M). GTBP (0) and VKTX (0) have equivalent revenues.
GTBPVKTXGTBP / VKTX
Capitalization6.68M7.34B0%
EBITDA-11.35M-133.66M8%
Gain YTD-60.915254.003-24%
P/E RatioN/AN/A-
Revenue00-
Total Cash9.25M930M1%
Total Debt01.24M-
FUNDAMENTALS RATINGS
GTBP vs VKTX: Fundamental Ratings
GTBP
VKTX
OUTLOOK RATING
1..100
2468
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
62
Fair valued
PROFIT vs RISK RATING
1..100
10027
SMR RATING
1..100
9892
PRICE GROWTH RATING
1..100
4235
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GTBP's Valuation (21) in the null industry is somewhat better than the same rating for VKTX (62) in the Biotechnology industry. This means that GTBP’s stock grew somewhat faster than VKTX’s over the last 12 months.

VKTX's Profit vs Risk Rating (27) in the Biotechnology industry is significantly better than the same rating for GTBP (100) in the null industry. This means that VKTX’s stock grew significantly faster than GTBP’s over the last 12 months.

VKTX's SMR Rating (92) in the Biotechnology industry is in the same range as GTBP (98) in the null industry. This means that VKTX’s stock grew similarly to GTBP’s over the last 12 months.

VKTX's Price Growth Rating (35) in the Biotechnology industry is in the same range as GTBP (42) in the null industry. This means that VKTX’s stock grew similarly to GTBP’s over the last 12 months.

VKTX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as GTBP (100) in the null industry. This means that VKTX’s stock grew similarly to GTBP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GTBPVKTX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 9 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
GTBP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BUZZ23.030.79
+3.55%
VanEck Social Sentiment ETF
KAPR33.781.04
+3.18%
Innovator Russell 2000 Pwr Bffr ETF Apr
JCPI47.030.07
+0.15%
JPMorgan Inflation Managed Bond ETF
JIRE62.29-1.05
-1.66%
JPMorgan International Rsrch Enh Eq ETF
SBB13.74-0.95
-6.47%
ProShares Short SmallCap600

GTBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, GTBP has been loosely correlated with PTCT. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if GTBP jumps, then PTCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GTBP
1D Price
Change %
GTBP100%
+3.10%
PTCT - GTBP
35%
Loosely correlated
+5.63%
AMRN - GTBP
33%
Poorly correlated
-4.96%
MDGL - GTBP
32%
Poorly correlated
+0.21%
VKTX - GTBP
31%
Poorly correlated
+1.93%
BPMUF - GTBP
29%
Poorly correlated
N/A
More

VKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VKTX has been loosely correlated with JANX. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if VKTX jumps, then JANX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VKTX
1D Price
Change %
VKTX100%
+1.93%
JANX - VKTX
63%
Loosely correlated
-0.76%
DNLI - VKTX
48%
Loosely correlated
+6.98%
LGND - VKTX
47%
Loosely correlated
+5.24%
ALT - VKTX
42%
Loosely correlated
+3.98%
BEAM - VKTX
42%
Loosely correlated
+11.24%
More